Operating

Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable

AbbVie Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable increased by 80.3% to -$81.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 121.4%, from $378.00M to -$81.00M. Over 2 years (FY 2021 to FY 2024), Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable shows a downward trend with a 58.9% CAGR.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026May 8, 2026

How to read this metric

An increase indicates tax deferral (positive for cash flow), while a decrease indicates a cash outflow to settle prior tax obligations.

Detailed definition

This represents the change in the company's net tax liability, reflecting the timing difference between tax expense reco...

Peer comparison

Standard line item in the operating section of the cash flow statement for all tax-paying entities.

Metric ID: operating_increase_decrease_in_income_taxes_payable_net__ad728c

Historical Data

17 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value-$753.00M-$66.00M-$662.00M$438.00M-$548.00M$294.00M$358.00M$187.00M-$1.12B$378.00M-$1.83B$0.00-$1.80B$378.00M-$1.38B-$411.00M-$81.00M
QoQ Change+91.2%-903.0%+166.2%-225.1%+153.6%+21.8%-47.8%-698.4%+133.8%-585.2%+100.0%+121.0%-463.8%+70.1%+80.3%
YoY Change+27.2%+545.5%+154.1%-57.3%-104.2%+102.1%-63.9%+0.0%+25.0%-121.4%
Range-$1.83B$438.00M
CAGR-42.7%
Avg YoY Growth+50.7%
Median YoY Growth+12.5%
Current Streak2 quarters growth

Frequently Asked Questions

What is AbbVie's increase (decrease) in income taxes payable, net of income taxes receivable?
AbbVie (ABBV) reported increase (decrease) in income taxes payable, net of income taxes receivable of -$81.00M in Q1 2026.
How has AbbVie's increase (decrease) in income taxes payable, net of income taxes receivable changed year-over-year?
AbbVie's increase (decrease) in income taxes payable, net of income taxes receivable decreased by 121.4% year-over-year, from $378.00M to -$81.00M.
What is the long-term trend for AbbVie's increase (decrease) in income taxes payable, net of income taxes receivable?
Over 2 years (2021 to 2024), AbbVie's increase (decrease) in income taxes payable, net of income taxes receivable has grown at a 58.9% compound annual growth rate (CAGR), from -$1.29B to -$3.26B.
What does increase (decrease) in income taxes payable, net of income taxes receivable mean?
The change in the amount of taxes owed but not yet paid to the government.